View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AU96 | Publication ID: Spring 2022 |
Title: ●Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Program for Contract Year 2024 (CMS-4201) | |
Abstract:
This proposed rule would implement changes to strengthen and improve the Medicare Advantage (Part C) and prescription drug (Part D) programs. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: Yes | Unfunded Mandates: No |
CFR Citation: 42 CFR 422 42 CFR 423 | |
Legal Authority: Pub. L. 115-271 |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Undetermined | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Christian Bauer Director, Division of Part D Policy Department of Health and Human Services Centers for Medicare & Medicaid Services Center for Medicare, MS: C1-26-16, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-6043 Email: christian.bauer@cms.hhs.gov |